why choose us

First received: October 20, 2023

Clinical Trial: A Study to Evaluate Treatment With Nivolumab Alone and Nivolumab Combined With Ipilimumab in Children With Melanoma

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Melanoma

Study Type: OBSERVATIONAL


Official Title: Real-World Evaluation of Patient Characteristics, Treatment Patterns, Safety, and Efficacy of Nivolumab Monotherapy and Nivolumab in Combination With Ipilimumab for Pediatric Melanoma

Brief Summary: The purpose of this study is to describe real-world safety outcomes in children with melanoma who are treated with nivolumab alone or nivolumab in combination with ipilimumab for unresectable or metastatic melanoma, or treated with adjuvant nivolumab after resection of stage IIB-IV melanoma.Demographic and clinical characteristics, and treatment patterns, will also be described in this population.

Read more